Literature DB >> 1633078

Clinical relevance of endothelium-derived relaxing factor (EDRF).

E Bassenge1.   

Abstract

1. In addition to metabolic and neurohumoral factors endothelium-derived autacoids like the nitric oxide radical NO and prostacyclin are effective regulators of vascular tone and thus tissue perfusion. NO is produced in endothelial cells from L-arginine by a Ca2+/calmodulin-dependent enzyme NO synthase. In addition, the NO radical is ultimately cleaved from all nitrovasodilators and resembles their vasoactive and antiaggregatory principle, which is used under pathological conditions as substitution therapy for impaired endothelial function and autacoid production. Impaired endothelium-dependent vasomotor control has been documented in hypercholesterolaemia, atheromatosis, diabetes, hypertension, and in reperfusion damage. L-arginine supplementation is effective in a few instances.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633078      PMCID: PMC1381221          DOI: 10.1111/j.1365-2125.1992.tb04147.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  50 in total

Review 1.  Endothelial and neuro-humoral control of coronary blood flow in health and disease.

Authors:  E Bassenge; G Heusch
Journal:  Rev Physiol Biochem Pharmacol       Date:  1990       Impact factor: 5.545

2.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  Endothelium-derived relaxant factor inhibits platelet activation.

Authors:  R Busse; A Lückhoff; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

4.  Dietary omega 3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries.

Authors:  H Shimokawa; P M Vanhoutte
Journal:  Am J Physiol       Date:  1989-04

5.  Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery.

Authors:  K Hongo; N F Kassell; T Nakagomi; T Sasaki; T Tsukahara; H Ogawa; D G Vollmer; R M Lehman
Journal:  J Neurosurg       Date:  1988-08       Impact factor: 5.115

6.  [Inhibition of thrombocyte aggregation and adhesion by endothelium-derived relaxant factor (EDRF) and their pathophysiologic significance].

Authors:  E Bassenge; R Busse; U Pohl
Journal:  Z Kardiol       Date:  1989

7.  Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.

Authors:  D G Harrison; M L Armstrong; P C Freiman; D D Heistad
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs.

Authors:  D J Stewart; J Holtz; E Bassenge
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

9.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

10.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

View more
  3 in total

1.  Metallo Protoporphyrin Functionalized Microelectrodes for Electrocatalytic Sensing of Nitric Oxide.

Authors:  Chen-Zhong Li; Subbiah Alwarappan; Wenbo Zhang; Nikki Scafa; Xueji Zhang
Journal:  Am J Biomed Sci       Date:  2009-05-22

Review 2.  Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.

Authors:  O Traub; R Van Bibber
Journal:  West J Med       Date:  1995-05

3.  Lentivirus‑mediated overexpression of CD97/ADGRE5 reverses dysregulated high glucose‑induced endothelial cell migration.

Authors:  Wenting Zhao; Zhen Wang; Zewei Sun; Shuai Wang; Mingjie Wu; Liangrong Zheng
Journal:  Mol Med Rep       Date:  2017-03-30       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.